Judge rejects auditor general's bid to access Vitalité's internal audits on travel nurses
Auditor General Paul Martin sought a court order to compel the regional health authority to disclose the documents as part of his investigation into the management and use of private agency nurses by Vitalité, Horizon and the Department of Social Development between Jan. 1, 2022, and Feb. 29, 2024.
But Court of King's Bench Chief Justice Tracey DeWare dismissed his application, saying she's not satisfied the Auditor General Act provides an explicit waiver of Vitalité's claims of litigation privilege or solicitor-client privilege.
These privileges are "foundational to our legal system," DeWare wrote in her decision, dated June 2.
"The Court can only endorse a legislative interpretation which abrogates these privileges in circumstances where the intention of the Legislature can be clearly discerned to have contemplated the scope of such an exceptional authority."
Vitalité is entitled to costs of $2,000, she ruled.
CBC News requested an interview with Martin, including whether he intends to appeal. In response, his office sent an emailed statement, saying he received notice of the dismissal last week and is "currently assessing the next steps."
Vitalité did not immediately respond to a request for comment.
In a scathing report last June, Martin concluded Vitalité spent $123 million in travel-nurse contracts dating back to 2022, when the regional health authority signed its first deal with Canadian Health Labs. The Ontario-based agency charged about $300 an hour per nurse — roughly six times what a local staff nurse earns.
"The contracts with private nursing agencies were not reflective of best practices and did not demonstrate value for money," Martin said at the time.
As part of that audit, launched in March 2024, Martin requested "various information and documents" from Vitalité, including internal audit reports on the use of agency nurses.
Internal audits were to probe 'irregularities'
Vitalité refused to provide the internal audit reports. It had commissioned the audits after it "noticed irregularities in some of the services rendered by the agency nurses which were not in conformity with the terms set out in the governing contracts," according to DeWare's decision.
No details are provided, but "in order to investigate potential deficiencies in the services rendered by the nursing agencies, [Vitalité] commissioned an internal audit of the performance of one of the contracts spanning the period between August 2022 and June 2023."
Vitalité alleges these audits "confirmed the existence of deficiencies in the performance of the agency nurses' contract with one of the agencies — Canadian Health Labs," DeWare wrote.
The company has since launched three lawsuits against Vitalité for allegedly breaching three of its contracts — two expired and one still in force. It's seeking compensation, including punitive, aggravated and special damages.
Vitalité has filed statements of defence, as well as counterclaims in all three cases.
Martin argued act covers privileged information
Martin applied to the court for an injunction on Oct. 9. "Under the Auditor General Act, I have rights of access to any information relating to the performance of my duties," he wrote in a sworn affidavit. This includes privileged information, he argued.
Section 13 (a) of the act says the auditor general is entitled to "free access at all convenient times to information, including files, documents, records, agreements and contracts, despite that they may be confidential or private, that relates to the fulfilment of his or her responsibilities."
According to Martin, changes the legislature made to that section in 2014, including the auditor general's ability to obtain "private and confidential" information, were specifically made to address this type of situation, DeWare wrote. Discussions surrounding the amendments demonstrate there was a clear desire to enhance the auditor general's authority to obtain necessary information, Martin argued.
Vitalité says disclosure would prejudice litigation
Vitalité countered that disclosure of the internal audit reports "would prejudice its ability to prosecute" the action against Canadian Health Labs, according to Deware, and that Section 13 (a) of the act "does not explicitly displace or supersede otherwise valid claims of litigation or solicitor-client privilege."
If the New Brunswick Legislature had intended for the section to override litigation or solicitor-client privilege, it would have explicitly stated so in the statute, as it does in the Ombudsman Act, Vitalité argued.
DeWare noted the Ontario Court of Appeal recently upheld a trial court decision that the Auditor General Act of that province, which, similar to New Brunswick's, does not contain a specific waiver of a valid privilege, "did not authorize access nor compel disclosure of privileged information."
The Supreme Court of Canada also considered a similar issue when interpreting a section of Alberta's Freedom of Information and Protection of Privacy Act in 2016, said DeWare. The country's highest court ruled legislative language must be interpreted restrictively when determining if solicitor-client privilege may be set aside.
Act not explicit, judge rules
"While I appreciate the [auditor general's] argument, the addition of the words 'confidential and private' to section 13 indicates an expanded scope to the information which could be sought, it falls short of explicitly stating an intention to have access to 'privileged' documents," DeWare said.
She pointed out that with the 2014 amendments, the legislature didn't adopt the "explicit" language of Nova Scotia's Auditor General Act — "solicitor-client privilege, litigation privilege, settlement privilege and public interest immunity."
"The language of the Nova Scotia statute could not be any clearer."
Section 13 (a) of the New Brunswick act "does not grant the Auditor General the authority to require production of documents or information which are properly subject to a solicitor-client or litigation privilege," DeWare ruled.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
9 minutes ago
- CTV News
Doctors are seeing more non-smokers, especially women, with later-stage lung cancer
Katie Hulan, 37, is one of a growing number of non-smoking women doctors are seeing who have lung cancer. Hulan is seen in an undated handout photo. THE CANADIAN PRESS/Handout - Mohammed Asaduallah (Mandatory Credit) TORONTO — Katie Hulan's family doctor thought she might have asthma. Her cough, which had started about a month and a half earlier, was getting progressively worse. So he gave her some puffers to try, but they didn't work. 'I was just getting to the point where I couldn't speak at work,' said the 37-year-old tech marketing manager. 'At the end of the day, I would be in pain just from the shaking and coughing.' Her doctor ordered an X-ray that showed a mass on her lung. '(My doctor) said to go to emergency, thinking it was a blood clot,' Hulan remembers. After about six hours of more tests, they told her she had stage 4 lung cancer. 'That was one of the most devastating moments of my life,' she said. 'My immediate reaction was, 'I know how this story ends.' And so for me, it just felt completely like a death sentence.' She had been healthy, active and didn't smoke. 'For me to get a cancer diagnosis was a big shock. And then to have a lung cancer diagnosis was very puzzling for me,' said Hulan, who was diagnosed in Toronto in late 2020 and has since moved to Victoria where she continues treatment. She's one of a growing number of non-smokers doctors are seeing with lung cancer. Although smoking remains the leading risk factor, the Canadian Cancer Society estimates about a quarter of lung cancer cases in the country are non-smokers. In addition, more of those non-smokers are women than men and it's not clear why, said Jessica Moffatt, vice-president of programs and advocacy at the Lung Health Foundation. 'One of the theories is that potentially estrogen is doing something to perpetuate tumour growth, but it's all theories at this point,' she said. What scientists do know is that environmental factors contribute to lung cancer risk, especially radon gas. According to Health Canada, long-term exposure to radon — an invisible, radioactive gas from the breakdown of uranium in soil and rocks — is the number one cause of lung cancer among non-smokers. The agency says radon is present to some degree in every home and urges everyone to get a radon test kit to check their levels. Other risk factors include exposure to second-hand smoke, asbestos and the fine particulate matter in air pollution, Moffatt said. As wildfires rage across the country, the effects of that smoke is 'a huge concern for us' and is an area being studied to determine lung cancer risk, she said. Dr. Rosalyn Juergens, a medical oncologist at McMaster University and Hamilton Health Sciences Centre, said studies have shown that people living in areas with high air pollution rates have a higher risk of developing lung cancer. Over about 20 years in practice, she has 'absolutely' seen a rise in non-smoking lung cancer patients. 'It was uncommon for me, not never, but uncommon for me, to see a never-smoker when I first started in practice. And we are definitely seeing more and more,' said Juergens, who is also the president of Lung Cancer Canada. It's not clear whether there are more non-smokers getting lung cancer or if they just make up a greater proportion of the patients as fewer people smoke than ever before, she said. Many of her non-smoking patients are women, but people simply aren't aware of lung cancer as a women's health issue, she said. When non-smokers reach her office, their cancer is often in advanced stages. 'More women will die of lung cancer than will die of breast cancer, ovarian cancer, and cervical cancer combined,' Juergens said. 'One in five of them will be people who have never touched a cigarette a day in their lives.' Although organized lung cancer screening programs have been running in British Columbia, Ontario and Nova Scotia since 2022, they only target smokers, so non-smokers don't get the benefit of that early detection. In addition, lung cancer is often not top-of-mind for primary-care providers when non-smoking patients come in with a cough, Juergens said. 'The tricky part about lung cancer is symptoms are generally very subtle, right? Your lungs inside don't have nerve endings. So it's not like you're going to get a pain. You're never going to feel a lump,' she said. But the good news for many patients, Juergens said, is that lung cancer treatment has advanced dramatically since the 1990s, when chemotherapy was often the only option. 'We do things called next generation sequencing on the vast majority of lung cancers, and that helps us to sort what exact type of lung cancer it is and pick the right treatments,' she said. That precision medicine turned Katie Hulan's initial life expectancy of six months into an average of five to six years. A biopsy showed that her cancer had an ALK genetic mutation — one of about a dozen biomarkers that have specific medications to target the cancerous cells, and is only present in about four per cent of cases. 'When I got that news, it felt like a 180. I had life. I had hope. You know, my oncologist sat down and said, 'you won the lottery, you have years,'' she said. Almost five years after her diagnosis, Hulan continues to take a pill as her treatment, never had to undergo chemotherapy, feels 'wonderful' and is determined to live a long, full life. She now does advocacy work for the Lung Health Foundation to call for equal access to targeted cancer medication across the country and to urge people to seek medical attention if they have a cough that lasts more than two or three weeks. 'I think the word on the street is that you have to be a person who has smoked and that's not at all the case,' she said. 'Anyone with lungs can get lung cancer.' This report by The Canadian Press was first published Aug. 18, 2025. Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content. Nicole Ireland, The Canadian Press
Globe and Mail
9 minutes ago
- Globe and Mail
Volatus Aerospace: Delivering Today, Building for Tomorrow – Positioned as Canada's Leader in Sovereign Aerial Solutions
TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Volatus Aerospace Inc. (TSXV: FLT, OTCQX: TAKOF, Frankfurt: ABB) today provided a corporate update, highlighting its strong financial position, expanding roster of international contracts, and alignment with Canada's defense and industrial priorities. With disciplined execution and growing global demand for advanced aerial solutions, Volatus is demonstrating momentum today while building the foundation for long-term leadership. Canada's reinforced focus on NATO readiness, Arctic sovereignty, and domestic industrial capacity mirrors Volatus' core strengths in intelligence, surveillance and reconnaissance ('ISR'), such as border and maritime surveillance, wildfire response, and reforestation, areas where the company is already providing solutions alongside Canadian and NATO-aligned partners. 'We have entered a period of unprecedented opportunity for Canadian aerospace and defense technology, and Volatus is strategically positioned to lead,' said Glen Lynch, CEO of Volatus Aerospace. 'Our strong balance sheet, regulatory readiness, and unmatched operational capabilities give us the runway to scale both in Canada and globally. We will execute with discipline, directing our capital and expertise on profitable growth, focus on converting our $600 million sales pipeline into long-term, multi-year contracts, accelerating domestic capacity, and solving real-world challenges for our clients and partners.' Demonstrated Momentum Strong Financial Position – Approximately $20 million of cash on the balance sheet and strong working capital provide runway to execute. The company has attracted long-term institutional support from partners including Investissement Québec (IQ), Export Development Canada (EDC), and other Quebec-based institutions. Contract Wins – Delivered approximately $5 million in ISR and public safety contracts, including deliveries to NATO partners and emergency response agencies. Regulatory Readiness – Secured multiple regulatory approvals enabling expanded remote operations, materially increasing the company's addressable market across defense, public safety, and industrial applications. Strategic Partnerships – Collaborations with various OEMS in Canada, the US and Europe expand capabilities in surveillance, heavy-lift cargo, and geospatial markets. Execution Capacity – The Operations Control Centre (OCC) enables Volatus to respond credibly and at scale to Canadian and international RFPs. Positioned for Long-Term Leadership Volatus enters its next phase with the resources, partnerships, and credibility to scale domestically and internationally, recognizing that the market for advanced aerial solutions is accelerating now, not years from today. Aligned with National Priorities – Canada's defense commitments and industrial capacity push directly align with Volatus' strengths across ISR, maritime surveillance, wildfire response, and reforestation. Building Sovereign Capacity – Investment in design, production, and secure supply chains positions Volatus to anchor a Canadian hub for drone manufacturing and advanced aerial capabilities with export potential. Regulatory Tailwinds – Evolving frameworks and recent approvals are unlocking scalable remote operations and creating new channels for service expansion and long-term contracts. Expanding Globally – Recent ISR, training, and heavy-lift engagements with NATO-aligned partners demonstrate credibility to pursue larger, multi-year mandates. Commercializing Innovation – Advancing AI-enabled software, counter-drone solutions, and RPAS platforms including the Condor XL heavy-lift program to address urgent defense and environmental applications. Disciplined Growth – With a strong cash position and clear focus, Volatus is prioritizing profitable growth through solution sales, aerial services, and training while continuing to invest in future-ready technologies and evaluating potential accretive acquisition opportunities. With the convergence of geopolitical demand, evolving regulatory frameworks, and Canada's commitment to economic and security independence, Volatus is advancing its mission to deliver innovative aerial solutions for intelligence, cargo, and environmental applications. The Company remains committed to disciplined execution, profitable growth, and creating enduring shareholder value. About Volatus Aerospace With 100+ years of combined aviation expertise, Volatus Aerospace delivers innovative global aerial solutions for intelligence and cargo, utilizing both piloted and remotely piloted aircraft (RPAS/drones). Committed to efficiency, safety, and sustainability, Volatus offers a complete ecosystem of aerial solutions including remote operations, enterprise equipment sales, training, and aerial services to enhance real-world applications across industries. Forward-Looking Information: This news release contains statements that constitute "forward-looking information" and "forward-looking statements" within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs, and current expectations of the Company with respect to future business activities and operating performance. Often, but not always, forward-looking information and forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates", or "believes" or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results "may", "could", "would", "might" or "will" (or other variations of the foregoing) be taken, occur, be achieved, or come to pass. Forward-looking information includes information about the Shares-for-Debt Transaction, including information regarding TSXV final approval of the Shares-for-Debt Transaction. Forward-looking information is based on currently available competitive, financial, and economic data and operating plans, strategies, or beliefs of management as of the date of this news release, but involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors may be based on information currently available to the Company, including information obtained from third-party industry analysts and other third-party sources, and are based on management's current expectations or beliefs. Any and all forward-looking information contained in this news release is expressly qualified by this cautionary statement. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Forward-looking information and forward-looking statements reflect the Company's current beliefs and is based on information currently available to it and on assumptions it believes to be not unreasonable in light of all of the circumstances. In some instances, material factors or assumptions are discussed in this news release in connection with statements containing forward-looking information. Such material factors and assumptions include, but are not limited to TSXV final approval of the Shares-for-Debt Transaction and including, but not limited to, those factors set forth in the Company's annual and quarterly management's discussion and analysis filed on Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. The forward-looking information contained herein is made as of the date of this news release and, other than as required by law, the Company disclaims any obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. There can be no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information.
CBC
13 minutes ago
- CBC
Fast-spreading fungus deadly to endangered butternut trees attacking 3 areas of P.E.I.
Islanders are being urged to take precautions to prevent the spread of a tree fungus that has now been detected in three areas of P.E.I. Butternut canker is a fast-spreading disease that attacks butternut trees. While the trees are not believed to be native to the Island, they are widely planted across the province. "It is really a death sentence, unfortunately, for the tree once it receives butternut canker," said Clay Cutting, a technician with the P.E.I. Invasive Species Council. Once the tree is infected, there is no known way to stop the fungus's spread — eventually, the host tree dies when multiple cankers work in conjunction to girdle the tree. Cutting said the council is well aware of how devastating the fungus can be to butternut tree populations because of how the disease has impacted other provinces. According to a news release from the P.E.I. Invasive Species Council, over 80 per cent of butternut trees in Ontario have been killed by butternut canker to date, with an overall infection rate of more than 99 per cent. Symptoms and signs The fungus was first observed in trees in Stratford's Robert Cotton Park in 2024. Since then, the invasive species council conducted surveys on butternut trees in Charlottetown and Stratford and found that a majority "demonstrated signs of butternut canker infection," according to the news release. Scientists with the Canadian Forest Service confirmed the identification of the disease in July. "The most obvious sign and symptoms of butternut canker are those large, sunken cankers that appear on the trunks in the branches. They're mostly elongated, and the cankers exude a black substance," Cutting said. He said the appearance of the fungus can differ based on how long the tree has been infected, and the time of year. The colouring of the infected area can range from black to dark brown. In newer cases, the symptoms are not as obvious and can look like raised patches with small cracks in the bark that exude a black substance. How does it spread? The only confirmed way butternut canker spreads is through rainfall, Cutting said. "The rainwater will hit an infected tree, maybe spread that around the canopy, splashing fungal spores around the canopy." He's not ruling out other methods of spread like the handling of firewood, or insects and birds coming into contact with the fungus. There are no known control methods for affected populations, and butternut trees' endangered status may limit their removal based on P.E.I.'s Wildlife Conservation Act regulations. The invasive species council said Islanders can take steps to care for certain trees that have show a higher level of tolerance to the disease. This can be done by pruning out infected branches and removing cankers to help minimize the amount of the fungus in the area to potentially extend the tree's lifespan.
